In July 2020, we published an article written by the team at Comate Engineering and Design explaining how they help ideas go “from core technology to marketable products.” We’re happy to bring you a new piece of their success story: CellSine.
CellSine is a revolutionary new technology for early stage drug testing. It could easily mean medications brought to patients faster and with less testing on animals. A win-win!
The technology behind CellSine, based on electrochemical impedance spectroscopy (EIS), was developed as part of a doctoral research project at the University of Leuven (KU Leuven) and the University of Brussels (VUB), resulting in a proof of concept. As anyone who’s brought a concept to market knows, though, this is but a step in a much longer process.
That’s where Comate came in. As they put it themselves, “CellSine relied on the expertise of Comate’s engineers and designers for the technical development, to translate the PoC into a market-ready product.”
Thanks to Comate’s expertise in taking a proof of concept to market, CellSine has launched a truly innovative device. Their ambitions run high, including integrating AI to their data analysis and boosting personalized medicine.
Read the whole story at Comate’s website.